| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/06/2007 | US20070280931 Antibody variants |
| 12/06/2007 | US20070280924 Pharmaceutical Preparations For And Treatment Of Ocular Surface and Other Disorders |
| 12/06/2007 | CA2653902A1 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653223A1 Therapeutic pyrrolidine compounds |
| 12/06/2007 | CA2652990A1 Therapeutic cyclopentane derivatives |
| 12/05/2007 | EP1861403A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/05/2007 | EP1861114A2 Compositions comprising modulators of g-protein-coupled receptor for treatment of macular degeneration |
| 12/05/2007 | EP1861081A1 Ophthalmic uses of s1p receptor modulators |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1539196B1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 12/05/2007 | EP1485359B1 Sodium channel blockers |
| 12/05/2007 | EP1208085B1 Benzanilides as potassium channel openers |
| 12/05/2007 | CN101083989A Use of thiazolidinone derivatives as antiangiogenic agents |
| 12/05/2007 | CN101081282A Chinese medicinal materials health products for treating aural vertigo |
| 12/05/2007 | CN101081277A Chinese herbal medicine bag tea preparation for preventing and treating the pain caused by the agnail and suppuration infection of inner and external auditory canal |
| 12/05/2007 | CN101081269A Natural Chinese herbal medicine cold tea preparation for preventing and treating inner and outer ear infection when removing pus and pain after suppuration |
| 12/05/2007 | CN101081256A Medicine having good function of treating eye disease |
| 12/05/2007 | CN101081249A Chinese medicinal materials for improving vision |
| 12/05/2007 | CN101081205A Instant jelly glue for eyes |
| 12/05/2007 | CN101081204A Method for preparation of cross-linking hyaluronic acid sodium jelly glue implanted in eyes |
| 12/05/2007 | CN101081091A Vision-improving and intelligent-improving beverage |
| 12/05/2007 | CN101081077A Double-blossom vision-improving millet gruel |
| 12/05/2007 | CN101081072A Selenium germanium peptide jujube tea paste for effecting radical cure of sugar diabetes |
| 12/05/2007 | CN101081049A Green grape health tea |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352508C Block polymer for eyes |
| 12/05/2007 | CN100352498C Three dimensional eye patch for treating eye wrinkles an its preparation method |
| 12/05/2007 | CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 12/05/2007 | CN100352493C Method of treating tumors |
| 12/05/2007 | CN100352458C Preparaton of banlangen and method for controlling quality |
| 12/04/2007 | US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists |
| 12/04/2007 | CA2255891C Compositions and methods for treating or preventing diseases of body passageways |
| 12/04/2007 | CA2192965C Anandamide analogue compositions and method of treating intraocular hypertension using same |
| 11/29/2007 | WO2007136759A2 Method for the treatment and prevention of ocular disorders |
| 11/29/2007 | WO2007136084A1 Agent for ameliorating the condition of sick building syndrome |
| 11/29/2007 | WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy |
| 11/29/2007 | WO2007135518A2 Use of choline-based preparations for the treatment of tinnitus |
| 11/29/2007 | WO2007135195A1 Ectonucleotidase inhibitors |
| 11/29/2007 | WO2007084473A3 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals |
| 11/29/2007 | WO2007038453A3 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
| 11/29/2007 | US20070276015 Crystal modification of torasemide |
| 11/29/2007 | US20070275995 Thiobenzimidazole derivatives |
| 11/29/2007 | US20070275965 CXCR4 modulators |
| 11/29/2007 | US20070274921 Diagnostics and therapeutics for ocular disorders |
| 11/29/2007 | DE202007011042U1 Polymorphe Formen von Flupirtinmaleat Polymorphic forms of flupirtine maleate |
| 11/29/2007 | CA2652662A1 Method for the treatment and prevention of ocular disorders |
| 11/28/2007 | EP1860113A1 Ectonucleotidase inhibitors |
| 11/28/2007 | EP1859813A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector |
| 11/28/2007 | EP1859802A2 Compositions comprising benzo(G)quinoline derivates and prostaglandin derivates |
| 11/28/2007 | EP1859795A1 Therapeutic agent for ophthalmic disease |
| 11/28/2007 | EP1858533A2 Use of amniotic fluid (af) in treating ocular disease and injury |
| 11/28/2007 | EP1858506A2 Methods of treating ear infections |
| 11/28/2007 | EP1858499A1 Methods for treatment of retinal degenerative disease |
| 11/28/2007 | EP1858497A2 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization |
| 11/28/2007 | EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 11/28/2007 | CN101077865A Phthalazines derivatives, preparation method thereof, medicament composition and use |
| 11/28/2007 | CN101077408A Oil of aromatic turmeric gel for ocular application and its production process |
| 11/28/2007 | CN101077352A Eye preparation containing lactose-azithromycin |
| 11/28/2007 | CN101077347A Multifunctional membrane used for glaucoma post-operation and preparation method thereof |
| 11/28/2007 | CN101077342A Method for formulating nutrition replenisher special-purpose used for children amblyopia |
| 11/28/2007 | CN101077212A Multi-flavor vision-improving beverage |
| 11/28/2007 | CN101077150A Bean product with eyesight-improving health care function and its manufacturing method |
| 11/28/2007 | CN101077115A Mulberry health and fragrant tea, preparation method and application |
| 11/28/2007 | CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 11/28/2007 | CN100351244C Bis-aromatic alkanols |
| 11/28/2007 | CN100350978C Medicine-carried degradable type lacrimal duct embolus, and its prepn. method |
| 11/28/2007 | CN100350976C Reversible gelling system for ocular drug delivery |
| 11/27/2007 | CA2400377C Method for treating ocular pain |
| 11/27/2007 | CA2379695C Compounds for modulating the rage receptor |
| 11/27/2007 | CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1 |
| 11/27/2007 | CA2253613C Therapeutic treatment for vegf related occular diseases |
| 11/22/2007 | WO2007134055A1 Antibacterial extracellular polysaccharide solvating system |
| 11/22/2007 | WO2007132846A1 Compound having acidic group which may be protected, and use thereof |
| 11/22/2007 | WO2007132718A1 Solid preparation comprising adenosine 5'-triphosphate or physiologically acceptable salt thereof |
| 11/22/2007 | WO2007132546A1 Pharmaceutical containing thiazole derivative as active ingredient |
| 11/22/2007 | WO2007115020A3 Therapeutic prostaglandin compounds for the treatment of glaucoma |
| 11/22/2007 | WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 11/22/2007 | WO2007022412A3 Combination therapy for preventing angiogenesis comprising a inhibitor ofhif-1 and a further anti-angiogenic agent |
| 11/22/2007 | US20070270490 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 11/22/2007 | US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 11/22/2007 | US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3 |
| 11/22/2007 | US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 11/22/2007 | US20070270378 Viscous Agent for Ophthalmic Use |
| 11/22/2007 | US20070270365 Treatment of Eye Disorders Characterized by an Elevated Intraocular Pressure by siRNAs |
| 11/22/2007 | US20070270346 Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
| 11/22/2007 | US20070270345 Periocular drug delivery for diabetic retinopathy |
| 11/22/2007 | US20070270344 Compositions and methods for treating ophthalmic disorders |
| 11/22/2007 | US20070269881 Carotene Synthase Gene and Uses Therefor |
| 11/22/2007 | US20070269869 culturing under conditions effective to produce lipids lacking pigmentation from microorganisms Thraustochytriales, genetically modified to selectively delete or inactivate a carotene synthase gene comprising a nucleic acid sequence codes a protein havng phytoene dehydrogenase, lycopene cyclase activity |
| 11/22/2007 | US20070269536 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals |